RecruitingNot ApplicableNCT07555652

Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy in Vietnam

Efficacy of Controlled Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy (HIE)

Sponsor

National Children's Hospital, Vietnam

Enrollment

120 participants

Start Date

Jun 10, 2025

Study Type

INTERVENTIONAL

Conditions

Hypoxic-ischemic encephalopathy (HIE)

Summary

This study aims to evaluate the effectiveness of therapeutic hypothermia in neonates diagnosed with hypoxic-ischemic encephalopathy (HIE). The study focuses on assessing both short-term outcomes after treatment and long-term neurological outcomes following therapeutic hypothermia.

Eligibility

Min Age: 0 HoursMax Age: 6 Hours

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Therapeutic Hypothermia for people with hypoxic-ischemic encephalopathy (hie). The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Hours to 6 Hours.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETherapeutic Hypothermia

Therapeutic hypothermia will be administered to neonates with HIE according to the protocolized technical procedure developed and standardized in the study. The intervention is initiated in eligible neonates within 6 hours after birth and is performed with continuous clinical and neurologic monitoring as specified in the protocol.